GreenLight Biosciences (GRNA)
0.30
0.00 (0.13%)
At close: Jul 21, 2023, 8:00 PM
Company Description
GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications.
Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops.
The company was founded in 2008 and is headquartered in Medford, Massachusetts.
GreenLight Biosciences

Country | United States |
IPO Date | Feb 3, 2022 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 280 |
CEO | Dr. Andrey Juan Zarur Ph.D. |
Contact Details
Address: 200 Boston Avenue Medford, Massachusetts United States | |
Website | https://greenlightbiosciences.com |
Stock Details
Ticker Symbol | GRNA |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001822691 |
CUSIP Number | 39536G105 |
ISIN Number | US39536G1058 |
Employer ID | 85-1914700 |
SIC Code | 2836 |
Key Executives
Name | Position |
---|---|
Dr. Andrey Juan Zarur Ph.D. | Co-Founder, Pres, Chief Executive Officer & Director |
Carole Beth Cobb M.B.A. | Chief Operating Officer |
Charu Manocha M.B.A. | Chief People Officer |
Dr. Drew Cunningham Ph.D. | Chief Technology Officer |
Susan E. Keefe M.B.A. | Chief Financial Officer & Interim Chief Accounting Officer |
David D. Kennedy Esq. | Advisor |
Dr. Amin Khan Ph.D. | Chief Science Officer of Human Health |
Dr. Mark T. Singleton Ph.D. | Chief Commercial Officer & Gen. Mang. of Plant Health |
Dr. Shelly Karuna | Chief Medical Officer |
Nina C. Thayer | Gen. Counsel |
Thomas Crampton | Senior Vice President & Head of Corporation Affairs |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Aug 11, 2023 | 15-12G | Filing |
Jul 28, 2023 | SC 13D/A | [Amend] Filing |
Jul 28, 2023 | SC 13D/A | [Amend] Filing |
Jul 28, 2023 | 8-K/A | [Amend] Current Report |
Jul 27, 2023 | SC 13D/A | [Amend] Filing |
Jul 27, 2023 | 4 | Filing |
Jul 27, 2023 | 3 | Filing |
Jul 27, 2023 | 4 | Filing |
Jul 27, 2023 | 4 | Filing |
Jul 27, 2023 | 4 | Filing |